1. A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway
   Xianzhou Huang et al, 2021, Biomaterials CrossRef
2. Repurposing autophagy regulators in brain tumors
   Edgar Petrosyan et al, 2022, International Journal of Cancer CrossRef
3. Sertraline repositioning: an overview of its potential use as a chemotherapeutic agent after four decades of tumor reversal studies
   João Luiz Baú-Carneiro et al, 2022, Translational Oncology CrossRef
4. Revisiting the Molecular Interactions between the Tumor Protein TCTP and the Drugs Sertraline/Thioridazine
   Florian Malard et al, 2022, ChemMedChem CrossRef
5. The application of antidepressant drugs in cancer treatment
   Yunxi Zheng et al, 2023, Biomedicine & Pharmacotherapy CrossRef
6. An Antidepressant Drug Increased TRAIL Receptor-2 Expression and Sensitized Lung Cancer Cells to TRAIL-induced Apoptosis
   Kazi Mohammad Ali Zinnah et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
7. Antidepressants as Autophagy Modulators for Cancer Therapy
   Leping He et al, 2023, Molecules CrossRef
8. TRPM2‐dependent autophagy inhibition exacerbates oxidative stress‐induced CXCL16 secretion by keratinocytes in vitiligo
   Pan Kang et al, 2024, The Journal of Pathology CrossRef
9. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
   Milad Ashrafizadeh et al, 2021, Life Sciences CrossRef
10. Repurposed Drugs in Gastric Cancer
    Diana Araújo et al, 2022, Molecules CrossRef
11. Antidepressant Drug Sertraline against Human Cancer Cells
    Diana Duarte et al, 2022, Biomolecules CrossRef